Samjin Pharmaceutical CEO Jo Gyu-seok to Receive 135,000 Shares as Gift from Jo Ui-hwan
Samjin Pharmaceutical CEO Jo Gyu-seok disclosed a plan to receive 135,000 common shares as a gift from Jo Ui-hwan via a report on transactions of specific securities.
The gift transaction is scheduled for August 10, 2026 as a single event, after which Jo's stake will increase from 3.19% to 4.20%.
This transaction represents 1.01% of total outstanding shares, is a private gift between individuals not involving market trading, and does not involve new share issuance or capital changes.
[AI Summary]This transaction is a personal gift to the CEO with no direct impact on the company's financial structure or shareholder value. No dilution effect exists as no new shares are issued, and it is evaluated as a neutral event in terms of management control.
KOSPI Filing Information
Report On Transaction Plan Of Specific Securities By Executives And Major Shareholders